A number of other brokerages also recently commented on ABC. Berenberg Bank reaffirmed a buy rating and set a GBX 1,100 ($14.52) price target on shares of Abcam Plc in a research report on Monday, September 11th. Panmure Gordon reaffirmed a sell rating on shares of Abcam Plc in a research report on Thursday, July 27th. Numis Securities Ltd reaffirmed an add rating and set a GBX 1,116 ($14.73) price target on shares of Abcam Plc in a research report on Thursday, July 27th. Finally, J P Morgan Chase & Co reaffirmed a neutral rating and set a GBX 864 ($11.40) price target on shares of Abcam Plc in a research report on Tuesday, September 12th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. The stock currently has an average rating of Hold and a consensus price target of GBX 972.67 ($12.84).
Shares of Abcam Plc (ABC) opened at GBX 1,042 ($13.75) on Tuesday.
TRADEMARK VIOLATION WARNING: This story was posted by BBNS and is owned by of BBNS. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://baseballnewssource.com/markets/abcam-plc-abc-rating-reiterated-by-peel-hunt/1746185.html.
The company also recently disclosed a dividend, which will be paid on Friday, December 8th. Shareholders of record on Thursday, November 16th will be issued a dividend of GBX 7.36 ($0.10) per share. This represents a yield of 0.71%. This is a positive change from Abcam Plc’s previous dividend of $2.83. The ex-dividend date is Thursday, November 16th.
In other Abcam Plc news, insider Jonathan Simon Milner sold 567,033 shares of the stock in a transaction on Thursday, September 21st. The stock was sold at an average price of GBX 1,017 ($13.42), for a total transaction of £5,766,725.61 ($7,609,825.30). Also, insider Louise Patten acquired 1,636 shares of Abcam Plc stock in a transaction on Thursday, September 14th. The shares were purchased at an average cost of GBX 1,079 ($14.24) per share, with a total value of £17,652.44 ($23,294.33).
About Abcam Plc
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.
Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with our FREE daily email newsletter.